Of note, recent studies have also shown that, in patients with CHIP and heart failure, CHIP mutated monocytes with DNMT3A driver mutations interact with cardiac fibroblasts and potentially increase cardiac fibrosis through increased release of heparin-binding epidermal growth factor-like growth factor that mediates cardiac fibroblast activation [19]. Here, DNMT3A is linked to heart failure.